The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review
出版年份 2017 全文链接
标题
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review
作者
关键词
-
出版物
Expert Review of Anticancer Therapy
Volume 17, Issue 9, Pages 827-839
出版商
Informa UK Limited
发表日期
2017-07-31
DOI
10.1080/14737140.2017.1360138
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Value of serum human epididymis secretory protein 4 as a marker for differential diagnosis of malignant and benign gynecological diseases of patients in southern China
- (2016) Laisheng Li et al. CLINICA CHIMICA ACTA
- CA125 and HE4: Measurement Tools for Ovarian Cancer
- (2016) Tingting Zhao et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study
- (2016) Cesare Romagnolo et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2016) Ian J Jacobs et al. LANCET
- Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses
- (2016) Katarzyna M. Terlikowska et al. Journal of Ovarian Research
- A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection
- (2015) Roberto Angioli et al. ANNALS OF SURGICAL ONCOLOGY
- Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening
- (2015) Robert A. Smith et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women
- (2015) Hye Yon Cho et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Comparison of HE4, CA125, and ROMA Diagnostic Accuracy
- (2015) Pengjun Zhang et al. MEDICINE
- The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients—results from the OVCAD study
- (2015) Mani Nassir et al. TUMOR BIOLOGY
- HE4 as a Serum Biomarker for ROMA Prediction and Prognosis of Epithelial Ovarian Cancer
- (2014) Wen-Ting Chen et al. Asian Pacific Journal of Cancer Prevention
- Prognostic Value of Serum HE4 Levels and Risk of Ovarian Malignancy Algorithm Scores at the Time of Ovarian Cancer Diagnosis
- (2014) Jeroen Kaijser et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women
- (2014) Hiroyuki Fujiwara et al. TUMOR BIOLOGY
- Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer?
- (2014) Roberto Angioli et al. TUMOR BIOLOGY
- Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer
- (2014) Tuulia Vallius et al. TUMOR BIOLOGY
- Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer
- (2014) Anita Chudecka-Głaz et al. Journal of Ovarian Research
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
- (2013) Penny F. Whiting ANNALS OF INTERNAL MEDICINE
- Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- HE4 Expression in Plasma Correlates with Surgical Outcome and Overall Survival in Patients with First Ovarian Cancer Relapse
- (2013) Elena Ioana Braicu et al. ANNALS OF SURGICAL ONCOLOGY
- Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?
- (2013) Amal Z. Azzam et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Diagnostic Value of Human Epididymis Protein 4 Compared with Mesothelin for Ovarian Cancer: a Systematic Review and Meta-analysis
- (2013) Jia-Ying Lin et al. Asian Pacific Journal of Cancer Prevention
- Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response
- (2013) Elham O Hamed et al. Diagnostic Pathology
- Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review
- (2013) Simona Ferraro et al. JOURNAL OF CLINICAL PATHOLOGY
- A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses
- (2012) C Anton et al. Clinics
- Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis
- (2012) JiaYing Lin et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass
- (2012) Mona Aarenstrup Karlsen et al. GYNECOLOGIC ONCOLOGY
- Human epididymis protein 4 (HE4) and ovarian cancer prognosis
- (2012) Dominique Trudel et al. GYNECOLOGIC ONCOLOGY
- Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: Correlation with pathological outcome
- (2012) M.T. Sandri et al. GYNECOLOGIC ONCOLOGY
- The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass
- (2012) Karen K.L. Chan et al. GYNECOLOGIC ONCOLOGY
- Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma?
- (2012) Roberto Angioli et al. GYNECOLOGIC ONCOLOGY
- Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients
- (2012) E.I. Braicu et al. GYNECOLOGIC ONCOLOGY
- Serum HE4 as a Useful Biomarker in Discriminating Ovarian Cancer From Benign Pelvic Disease
- (2012) Hong Zheng et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The Prognostic and Predictive Value of Combined HE4 and CA-125 in Ovarian Cancer Patients
- (2012) Karina Dahl Steffensen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The Utility of Human Epididymal Protein 4, Cancer Antigen 125, and Risk for Malignancy Algorithm in Ovarian Cancer and Endometriosis
- (2012) Sasa Kadija et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Diagnostic Value of Serum Human Epididymis Protein 4 (HE4) in Ovarian Carcinoma
- (2012) Li Wu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass
- (2012) Karolina Partheen et al. Journal of Gynecologic Oncology
- Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer
- (2012) Teresa Granato et al. TUMOR BIOLOGY
- Does HE4 have a role as biomarker in the recurrence of ovarian cancer?
- (2012) Francesco Plotti et al. TUMOR BIOLOGY
- Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS)
- (2012) A. Sharma et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer
- (2012) Grigorios Kalapotharakos et al. Journal of Ovarian Research
- Serum HE4 Level is an Independent Prognostic Factor in Epithelial Ovarian Cancer
- (2011) Sun-Young Kong et al. ANNALS OF SURGICAL ONCOLOGY
- HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
- (2011) T Van Gorp et al. BRITISH JOURNAL OF CANCER
- Serum Human Epididymis Protein 4 and Risk for Ovarian Malignancy Algorithm as New Diagnostic and Prognostic Tools for Epithelial Ovarian Cancer Management
- (2011) E. Bandiera et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
- (2011) D. W. Cramer et al. Cancer Prevention Research
- HE4 and epithelial ovarian cancer: Comparison and clinical evaluation of two immunoassays and a combination algorithm
- (2011) Giuseppina Ruggeri et al. CLINICA CHIMICA ACTA
- Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases
- (2011) Yongjung Park et al. CLINICAL BIOCHEMISTRY
- Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases
- (2011) J. M. Escudero et al. CLINICAL CHEMISTRY
- The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses
- (2011) Miriam Lenhard et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population
- (2011) Yong Man Kim et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
- (2011) Martina Montagnana et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer
- (2011) Jiheum Paek et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting
- (2011) Francis Jacob et al. GYNECOLOGIC ONCOLOGY
- Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125
- (2011) Michèl Schummer et al. GYNECOLOGIC ONCOLOGY
- Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer
- (2011) Yongjung Park et al. INTERNATIONAL JOURNAL OF CANCER
- Serum HE4 Profile During Primary Chemotherapy of Epithelial Ovarian Cancer
- (2011) Johanna Hynninen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Human Epididymis Protein 4 (HE4) as a Serum Tumor Biomarker in Patients With Ovarian Carcinoma
- (2011) Xiaohong Chang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Effect of Screening on Ovarian Cancer Mortality
- (2011) Saundra S. Buys JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Committee Opinion No. 477: The Role of the Obstetrician–Gynecologist in the Early Detection of Epithelial Ovarian Cancer
- (2011) OBSTETRICS AND GYNECOLOGY
- Comprehensive Serum Profiling for the Discovery of Epithelial Ovarian Cancer Biomarkers
- (2011) Ping Yip et al. PLoS One
- HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
- (2011) Rafael Molina et al. TUMOR BIOLOGY
- OC21.03: Ultrasound imaging compared to a multivariate predictive algorithm combining HE4 and CA 125 (ROMA®) in the pre-operative assessment of adnexal masses
- (2011) D. Franchi et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass
- (2010) Brian Nolen et al. GYNECOLOGIC ONCOLOGY
- SGO White Paper on Ovarian Cancer: Etiology, Screening and Surveillance
- (2010) John O. Schorge et al. GYNECOLOGIC ONCOLOGY
- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
- (2010) Gordon JS Rustin et al. LANCET
- HE4: a new potential early biomarker for the recurrence of ovarian cancer
- (2010) Emanuela Anastasi et al. TUMOR BIOLOGY
- ACR Appropriateness Criteria© Ovarian Cancer Screening
- (2010) Douglas L. Brown et al. Ultrasound Quarterly
- Influence of Ovarian Cancer Risk Status on the Diagnostic Performance of the Serum Biomarkers Mesothelin, HE4, and CA125
- (2009) C. A. Shah et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
- (2009) M. Robyn Andersen et al. GYNECOLOGIC ONCOLOGY
- The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass
- (2009) Martina Montagnana et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
- (2009) Usha Menon et al. LANCET ONCOLOGY
- Screening for Ovarian Cancer
- (2009) Daniel L. Clarke-Pearson NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence
- (2008) Laura J. Havrilesky et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started